Omega-3 Supplementation After Surgical Treatment of Obesity

NCT06494566 — Early Phase 1, Completed, 150 participants, Instituto de Cardiologia do Rio Grande do Sul

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Diet Supplementation of Omega-3 Fatty Acids After Surgical Treatment of Obesity: a Randomized Clinical Trial

RegistryNCT06494566
StatusCompleted
PhaseEarly Phase 1
Study typeInterventional; randomized, parallel, masking: quadruple, prevention
Enrollment150 (Actual)
SponsorInstituto de Cardiologia do Rio Grande do Sul (Other)
ConditionsObesity
InterventionsOmega-3, Mineral Oil (Dietary supplement)
Datesstart 2019-04-10, primary completion 2023-07-30, completion 2023-12-04, first posted 2024-07-10, last updated 2024-07-10
Locations2 sites in Brazil

Related Papers Related Patents Related Grants Related Experts
All trials for Obesity All trials of Omega-3 All trials of Mineral Oil

-Summary

The study evaluates diet supplementation of Omega-3 fatty acids after surgical treatment of obesity in adults. Half participants will receive diet supplementation of Omega-3 fatty acids, while the other half will receive placebo.

Expand all sections  ·  Collapse all

+Detailed description

Omega-3 fatty acids has been related to immunomodulation and antioxidant action. Diet supplementation of Omega-3 fatty acids after surgical treatment of obesity may help stabilize protein catabolism, reduce peroxidative damage, and improve lipid profile.

+Arms and interventions

ArmTypeInterventionsDescription
Omega-3Active comparatorDietary Supplement: Omega-3Omega-3 2000mg (940mg of EPA and 660mg of DHA) in gastro resistant capsule by mouth once a day for 90 days, starting on day sixteen after surgery.
PlaceboPlacebo comparatorDietary Supplement: Mineral OilMineral oil capsule by mouth once a day for 90 days, starting on day sixteen after surgery.
  • Omega-3 (Dietary supplement): Omega-3 capsule
  • Mineral Oil (Dietary supplement): Mineral Oil Capsule

+Outcome measures

Primary outcomes

  • Weight [Assessment points: first and last preoperative nutritional assessment, fifteen days and three and a half months after surgery.]: Measurement with digital scale, patient standing, barefoot. kilograms (kg)
  • Height [Points of evaluation: first and last preoperative nutritional assessment, fifteen days and three and a half months after surgery.]: Height measurement, patient standing, barefoot. Unit of measurement: meters (m).

Secondary outcomes

  • Manual Grip Strength [Assessment points: first and last preoperative nutritional assessment, fifteen days and three and a half months after surgery.]: Best of three handgrip strength measurements, patient seated, arm supported. Unit of measurement: kilograms-force (kgf).
  • 6-Minute Walk Test [Points of evaluation: first and last preoperative nutritional assessment, fifteen days and three months and medium after surgery.]: Walking with measurements of distance covered. Units of measurement: meters.
  • Electrical Bioimpedance - Percentage of muscle mass [Assessment points: first and last preoperative nutritional assessment, fifteen days and three and a half months after surgery.]: Electrical bioimpedance scale measurement. Unit of measurement: percentage (%).
  • Electrical Bioimpedance - Body fat percentage [Assessment points: first and last preoperative nutritional assessment, fifteen days and three and a half months after surgery.]: Electrical bioimpedance scale measurement. Unit of measurement: percentage (%).

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* BMI > 30kg/m2
* Candidate to bariatric and metabolic surgery

Exclusion Criteria:

* Use of Omega-3
* Contraindication to bioimpedance analysis
* Uso of steroids, non steroidal inflammatory drugs, immunomodulators or antibiotics
* Refusal to participate

+Locations (2)

FacilityCityCountryStatus
Irmandade Santa Casa de Misericórdia de Porto AlegrePorto Alegre, Rio Grande do SulBrazil
Instituto de CardiologiaPorto Alegre, Rio Grande do SulBrazil

+Publications

  • Results publication: Bigolin AV, Iaroseski J, Carteri RB, Rodrigues GS, de Andrade R, De Carli LA, Razzera EL, Vian I, de Almeida da Silva R, Kalil AN, Ferreira LF. Effects of Omega-3 Supplementation in Sarcopenia After Bariatric Surgery: A Triple-Blind Randomized Controlled Clinical Trial. J Cachexia Sarcopenia Muscle. 2026 Jun;17(3):e70321. doi: 10.1002/jcsm.70321. PMID 42289186